Intellectual Disability
|
0.400 |
Biomarker
|
group |
CTD_human |
Targeted sequencing identifies 91 neurodevelopmental-disorder risk genes with autism and developmental-disability biases.
|
28191889 |
2017 |
Intellectual Disability
|
0.400 |
GeneticVariation
|
group |
BEFREE |
We identified 41 (0.21%) previously unreported exonic NRXN1 deletions ascertained for developmental delay/intellectual disability that were significantly greater than in controls (odds ratio (OR) = 8.14; 95% confidence interval (CI): 2.91-22.72; P < 0.0001).
|
27195815 |
2017 |
Intellectual Disability
|
0.400 |
Biomarker
|
group |
BEFREE |
Studies of genomic copy number variants (CNVs) have identified genes associated with autism spectrum disorder (ASD) and intellectual disability (ID) such as NRXN1, SHANK2, SHANK3 and PTCHD1.
|
25131214 |
2015 |
Intellectual Disability
|
0.400 |
GeneticVariation
|
group |
BEFREE |
Deletions and point mutations in the neurexin 1 (NRXN1) gene are associated with a broad spectrum of neuropsychiatric and neurodevelopmental disorders, including autism, intellectual disability, epilepsy, developmental delay, and schizophrenia.
|
24633560 |
2014 |
Intellectual Disability
|
0.400 |
GeneticVariation
|
group |
BEFREE |
The coding regions in 24 exons and exon-intron boundaries of the NRXN1 gene were investigated in 115 Thai patients with ID and ASD by direct DNA sequencing.
|
24832020 |
2014 |
Intellectual Disability
|
0.400 |
Biomarker
|
group |
BEFREE |
Our cases expand the phenotype of biallelic α NRXN 1 mutations and emphasize the important role of NRXN1 in autism and intellectual disability.
|
25149956 |
2014 |
Intellectual Disability
|
0.400 |
AlteredExpression
|
group |
BEFREE |
Overall, 16p11.2 CNV was associated with altered expression of genes and networks that converge on multiple hypotheses of ASD pathogenesis, including synaptic function (e.g., NRXN1, NRXN3), chromatin modification (e.g., CHD8, EHMT1, MECP2), transcriptional regulation (e.g., TCF4, SATB2), and intellectual disability (e.g., FMR1, CEP290).
|
24906019 |
2014 |
Intellectual Disability
|
0.400 |
AlteredExpression
|
group |
BEFREE |
Mutations affecting synaptic levels of neurexin-1β in autism and mental retardation.
|
22504536 |
2012 |
Intellectual Disability
|
0.400 |
GeneticVariation
|
group |
BEFREE |
Mutations in neurexin 1 (NRXN1) as well as two other members of the neuroligin family, NLGN3 and NLGN4, have been associated with autism and mutations in NLGN4 have also been associated with intellectual disability, seizures, and EEG abnormalities.
|
22106001 |
2012 |
Intellectual Disability
|
0.400 |
GeneticVariation
|
group |
BEFREE |
Copy number variants (CNVs) and intragenic rearrangements of the NRXN1 (neurexin 1) gene are associated with a wide spectrum of developmental and neuropsychiatric disorders, including intellectual disability, speech delay, autism spectrum disorders (ASDs), hypotonia and schizophrenia.
|
22617343 |
2012 |
Intellectual Disability
|
0.400 |
AlteredExpression
|
group |
BEFREE |
Mutation of the neurexin1-gene, NRXN1, interrupting the expression of neurexin1 has been associated with schizophrenia, autism, and intellectual disability.
|
22337556 |
2012 |
Intellectual Disability
|
0.400 |
GeneticVariation
|
group |
BEFREE |
CNTNAP2 and NRXN1 are mutated in autosomal-recessive Pitt-Hopkins-like mental retardation and determine the level of a common synaptic protein in Drosophila.
|
19896112 |
2009 |
Intellectual Disability
|
0.400 |
GeneticVariation
|
group |
BEFREE |
Mutations in NLGN3/4, SHANK3, or NRXN1 alter synaptic function and lead to mental retardation, typical autism, or Asperger syndrome.
|
19545994 |
2009 |
Intellectual Disability
|
0.400 |
Biomarker
|
group |
CTD_human |
A patient with vertebral, cognitive and behavioural abnormalities and a de novo deletion of NRXN1alpha.
|
18057082 |
2008 |